Shufro Rose & Co’s Cigna CI Stock Holding History

Shufro Rose & Co’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,285	Closed	-$244K	–	304
2018 Q4	$244K	Buy	+1,285	New	+$268K	0.03%	228

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Shufro Rose & Co's CI Position: Q1 2019 in Review

Shufro Rose & Co sold out of Cigna (CI) in Q1 2019, closing a stake of 1,285 shares — an estimated $244K sold.

Shufro Rose & Co first reported a position in CI in Q4 2018 and held it in 1 quarter. The position peaked at $244K in Q4 2018. 1,127 funds tracked by Wall St. Rank hold CI as of Q1 2019.

Shufro Rose & Co reported no remaining Cigna position as of Q1 2019 after selling out during the quarter.
Shufro Rose & Co sold 1,285 Cigna shares in Q1 2019, an estimated $244K.
Shufro Rose & Co first reported a position in Cigna in Q4 2018 and held it in 1 quarter.
Shufro Rose & Co's Cigna position peaked at $244K in Q4 2018.
1,127 funds tracked by Wall St. Rank held Cigna as of Q1 2019.

Based on Shufro Rose & Co's 13F filing for Q1 2019, filed 3 May 2019.